Related Experiment Video
Updated: Jun 15, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Mucopolysaccharidosis type IIID: 12 new patients and 15 novel mutations
Marlies J Valstar1, Aida M Bertoli-Avella, Marja W Wessels
1Department of Clinical Genetics, Erasmus University Medical Center, Dr. Molewaterplein 50, Rotterdam, The Netherlands.
Abstract:
Mucopolysaccharidosis III D (Sanfilippo disease type D, MPS IIID) is a rare autosomal recessive lysosomal storage disorder previously described in only 20 patients. MPS IIID is caused by a deficiency of N-acetylglucosamine-6-sulphate sulphatase (GNS), one of the enzymes required for the degradation of heparan sulphate. So far only seven mutations in the GNS gene have been reported. The clinical phenotype of 12 new MPS IIID patients from 10 families was studied. Mutation analysis of GNS was performed in 16 patients (14 index cases). Clinical signs and symptoms of the MPS IIID patients appeared to be similar to previously described patients with MPS III. Early development was normal with onset of behavioral problems around the age of 4 years, followed by developmental stagnation, deterioration of verbal communication and subsequent deterioration of motor functions. Sequence analysis of the coding regions of the gene encoding GNS (GNS) resulted in the identification of 15 novel mutations: 3 missense mutations, 1 nonsense mutation, 4 splice site mutations, 3 frame shift mutations, 3 large deletions and 1 in-frame small deletion. They include the first missense mutations and a relatively high proportion of large rearrangements, which warrants the inclusion of quantitative techniques in routine mutation screening of the GNS gene.
Insights
Mucopolysaccharidosis III D (MPS IIID) is a rare genetic disorder. Researchers identified 15 new mutations in the GNS gene, expanding understanding of this lysosomal storage disease.
Area of Science:
- Genetics
- Biochemistry
- Rare Diseases
Background:
- Mucopolysaccharidosis III D (MPS IIID), also known as Sanfilippo disease type D, is a rare autosomal recessive lysosomal storage disorder.
- It results from a deficiency in N-acetylglucosamine-6-sulphate sulphatase (GNS), an enzyme crucial for heparan sulphate degradation.
- Previously, only 20 patients and seven GNS gene mutations were documented.
Purpose of the Study:
- To investigate the clinical phenotype of new MPS IIID patients.
- To identify novel mutations in the GNS gene in a cohort of patients with suspected MPS IIID.
- To characterize the spectrum of genetic alterations in the GNS gene associated with MPS IIID.
Main Methods:
- Clinical data from 12 new MPS IIID patients from 10 families were collected and analyzed.
- Mutation analysis of the GNS gene was performed in 16 patients, including 14 index cases.
- Sequence analysis of the coding regions of the GNS gene was employed to identify mutations.
Main Results:
- The clinical presentation of the studied MPS IIID patients aligns with previously described cases, characterized by normal early development followed by behavioral issues, developmental stagnation, and progressive decline in communication and motor skills.
- Sequence analysis identified 15 novel mutations in the GNS gene, including 3 missense, 1 nonsense, 4 splice site, 3 frameshift, 3 large deletions, and 1 in-frame small deletion.
- These findings include the first reported missense mutations and a significant proportion of large rearrangements in the GNS gene.
Conclusions:
- The study expands the mutational landscape of MPS IIID by identifying numerous novel GNS gene mutations.
- The findings highlight the importance of including quantitative techniques for detecting large rearrangements in routine GNS gene mutation screening for MPS IIID.
- This research contributes to a better understanding of the genetic basis and clinical spectrum of MPS IIID, aiding in diagnosis and potential therapeutic strategies.
Related Concept Videos
Lysosomal Hydrolases
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pleiotropy
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Single Nucleotide Polymorphisms-SNPs

